drugset / Trial / NCT02330094

Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage

NCT02330094

Phase 4 Completed 16 enrolled Mayo Clinic
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to see how much gabapentin will reduce headaches associated with subarachnoid hemorrhage (SAH) and to reduce the amount of narcotic pain medication prescribed.

Timeline

Start
2014-12
Primary completion
2017-09-01
Completion
2017-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule Oral